Metabolic and Hematologic Genetic Diseases

A genetic risk score for coronary artery disease shifts your odds, not your fate. Here is what the research shows, in plain out-of-100 numbers.

Gout needs two inherited systems to fail, not just uric acid. What ABCG2, SLC2A9 and a genome-wide study of 2.6 million people actually show.

A consumer type 2 diabetes score is a population probability, not a diagnosis. What 611 loci, the DPP trial and US and Canadian rules actually say.

An FAH carrier flag is not a diagnosis. A research-grounded guide to tyrosinemia type I: the inheritance math, testing in the US and Canada, and nitisinone.

A DTC report flagged your Prothrombin G20210A variant? A research-grounded look at what your roughly 3-4x clot risk means in absolute terms, plus testing, GINA, and family guidance.

A carrier line on a 23andMe report is not a diagnosis. Grounded in the first 2024 HFI clinical guidelines, StatPearls, and NIH, here is what ALDOB carrier status means for you and your family.

A flagged newborn screen for MCAD deficiency is common and manageable. This research-grounded guide explains inheritance, testing, day-to-day care, and family impact for US and Canada families.

A research-grounded guide to what an ATP7B carrier flag really means, why a single variant almost never makes you sick, how Wilson disease is truly diagnosed, and what to do next.

A worried 23andMe GRHPR carrier's plain-English guide to primary hyperoxaluria type 2: what one variant means, real recurrence numbers, testing, and the honest facts on new RNAi drugs.

A research-grounded, US and Canada guide to a PKLR carrier result: what it means for you and your children, how to confirm it, and where mitapivat (Pyrukynd) stands.